|
1
|
Pittenger MF, Mackay AM, Beck SC, et al:
Multilineage potential of adult human mesenchymal stem cells.
Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tuli R, Tuli S, Nandi S, et al:
Characterization of multipotential mesenchymal progenitor cells
derived from human trabecular bone. Stem Cells. 21:681–693. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Le Blanc K and Pittenger M: Mesenchymal
stem cells: progress toward promise. Cytotherapy. 7:36–45.
2005.PubMed/NCBI
|
|
4
|
Huang J, Zhao L, Xing L and Chen D:
MicroRNA-204 regulates Runx2 protein expression and
mesenchymal progenitor cell differentiation. Stem Cells.
28:357–364. 2010.
|
|
5
|
Eskildsen T, Taipaleenmäki H, Stenvang J,
et al: MicroRNA-138 regulates osteogenic differentiation of human
stromal (mesenchymal) stem cells in vivo. Proc Natl Acad Sci USA.
108:6139–6144. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang JF, Fu WM, He ML, et al: MiR-637
maintains the balance between adipocytes and osteoblasts by
directly targeting Osterix. Mol Biol Cell. 22:3955–3961. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Willimott S and Wagner SD: MiR-125b
and miR-155 contribute to bcl2 repression and proliferation
in response to CD40 ligand (CD154) in human leukemic
B-cells. J Biol Chem. 287:2608–2617. 2012.PubMed/NCBI
|
|
8
|
Scott GK, Goga A, Bhaumik D, et al:
Coordinate suppression of ERBB2 and ERBB3 by enforced expression of
micro-RNA miR-125a or miR-125b. J Biol Chem. 282:1479–1486.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu LH, Li H, Li JP, et al:
miR-125b suppresses the proliferation and migration of
osteosarcoma cells through down-regulation of STAT3. Biochem
Biophys Res Commun. 416:31–38. 2011.
|
|
10
|
Lin KY, Zhang XJ, Feng DD, et al:
miR-125b, a target of CDX2, regulates cell differentiation
through repression of the core binding factor in hematopoietic
malignancies. J Biol Chem. 286:38253–38263. 2011.PubMed/NCBI
|
|
11
|
Manolagas SC and Jilka RL: Bone marrow,
cytokines, and bone remodeling. Emerging insights into the
pathophysiology of osteoporosis. N Engl J Med. 332:305–311. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Verma S, Rajaratnam JH, Denton J, et al:
Adipocytic proportion of bone marrow is inversely related to bone
formation in osteoporosis. J Clin Pathol. 55:693–698. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yoshida CA, Yamamoto H, Fujita T, et al:
Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2
regulates limb growth through induction of Indian hedgehog. Genes
Dev. 18:952–963. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nakashima K, Zhou X, Kunkel G, et al: The
novel zinc finger-containing transcription factor osterix is
required for osteoblast differentiation and bone formation. Cell.
108:17–29. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pittenger MF, Mackay AM, Beck SC, et al:
Multilineage potential of adult human mesenchymal stem cells.
Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gallagher JC and Sai AJ: Molecular biology
of bone remodeling: implications for new therapeutic targets for
osteoporosis. Maturitas. 65:301–307. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bellantuono I, Aldahmash A and Kassem M:
Aging of marrow stromal (skeletal) stem cells and their
contribution to age-related bone loss. Biochim Biophys Acta.
1792:364–370. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gao J, Yang T, Han J, et al: MicroRNA
expression during osteogenic differentiation of human multipotent
mesenchymal stromal cells from bone marrow. J Cell Biochem.
112:1844–1856. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Goff LA, Boucher S, Ricupero CL, et al:
Differentiating human multipotent mesenchymal stromal cells
regulate microRNAs: prediction of microRNA regulation by PDGF
during osteogenesis. Exp Hematol. 36:1354–1369. 2008. View Article : Google Scholar
|
|
20
|
Shi L, Zhang J, Pan T, et al:
MiR-125b is critical for the suppression of human U251
glioma stem cell proliferation. Brain Res. 1312:120–126.
2010.PubMed/NCBI
|
|
21
|
Zhang ZJ, Zhang H, Kang Y, et al: miRNA
expression profile during osteogenic differentiation of human
adipose-derived stem cells. J Cell Biochem. 113:888–898.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mizuno Y, Yagi K and Tokuzawa Y:
miR-125b inhibits osteoblastic differentiation by
down-regulation of cell proliferation. Biochem Biophys Res
Commun. 368:267–272. 2008.
|
|
23
|
Goettsch C, Rauner M, Pacyna N, et al:
miR-125b regulates calcification of vascular smooth muscle
cells. Am J Pathol. 179:1594–1600. 2011.PubMed/NCBI
|
|
24
|
Liu F, Akiyama Y, Tai S, et al: Changes in
the expression of CD106, osteogenic genes, and transcription
factors involved in the osteogenic differentiation of human bone
marrow mesenchymal stem cells. J Bone Miner Metab. 26:312–320.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Le MTN, Shyh-Chang N, Khaw SL, et al:
Conserved regulation of p53 network dosage by microRNA-125b
occurs through evolving miRNA-target gene pairs. PLoS Genet.
7:e10022422011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Armesilla-Diaz A, Elvira G and Silva A:
p53 regulates the proliferation, differentiation and spontaneous
transformation of mesenchymal stem cells. Exp Cell Res.
315:3598–3610. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu H and Li B: p53 control of bone
remodeling. J Cell Biochem. 111:529–534. 2010. View Article : Google Scholar
|
